Streetbeat News

Analyst Ratings

BFH

Shares of Bread Financial Holdings are trading lower following downgrades by RBC and Raymond James analysts.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 7:41 pm

VTGN

Maxim Group analyst Jason McCarthy has maintained a 'Buy' rating on Vistagen Therapeutics (NASDAQ:VTGN) and kept the price target at $30.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 7:35 pm

DVN

A significant amount of unusual options activity has been observed for Devon Energy (NYSE:DVN), with a majority of investors taking a bullish stance. The trades range from $40.0 to $65.0 for Devon Energy over the last 3 months. The price of DVN is up 1.49% at $53.71. Analysts from Wells Fargo, Piper Sandler, Stifel, UBS, and Mizuho have maintained their ratings on Devon Energy, with price targets ranging from $51 to $79.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 7:16 pm

COP

A significant bearish stance has been taken on ConocoPhillips (NYSE:COP) by a large investor, as observed in the options history. The sentiment among these big-money traders is split between 41% bullish and 58% bearish. The whales have been targeting a price range from $105.0 to $130.0 for ConocoPhillips over the last 3 months. The price of COP is up 1.16% at $123.55. Analysts from Mizuho, Jefferies, and UBS have maintained their ratings on ConocoPhillips, while RBC Capital has downgraded its action to Outperform.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 7:15 pm

AFRM

Mizuho analyst Dan Dolev has maintained a Buy rating for Affirm Holdings Inc (NASDAQ:AFRM) and raised the price target from $20 to $25. Dolev is encouraged by the early results of the Affirm Card and sees potential for growth as the card is adopted by more of AFRM's 16.5 million customers. He has raised FY24 and FY25 revenue and adjusted operating income estimates based on 4Q results and management's fresh guidance. Despite potential negative catalysts, Dolev remains bullish on AFRM's prospects.

Portfolio Pulse from Anusuya Lahiri

September 05, 2023 | 7:13 pm

ADP

RBC Capital Markets analyst Ashish Sabadra initiated coverage on Automatic Data Processing Inc (ADP) with a Sector Perform rating and a price target of $267. Sabadra praised ADP's diversified revenue portfolio and strong platform, but noted potential macro headwinds that could impact employment and customer spending. The analyst also projected a slowdown in pays-per-control and lower Employer Services retention for FY24.

Portfolio Pulse from Lekha Gupta

September 05, 2023 | 7:09 pm

NSA

BMO Capital Markets analyst Juan C. Sanabria reiterated a Market Perform rating on National Storage Affiliates Trust (NYSE:NSA) with a price target of $35. NSA's asset growth and rising interest rates are noted, with the company's focus on secondary markets and potential for future efficiencies highlighted. NSA's shares are currently trading lower by 0.77% to $33.71.

Portfolio Pulse from Nabaparna Bhattacharya

September 05, 2023 | 7:05 pm

GMAB

Analysts have provided a mix of bullish and bearish ratings for Genmab (NASDAQ:GMAB) in the last quarter. The average price target is $42.29, which is higher than the current price of $37.99. This average has increased by 28.15% from the previous average price target of $33.00.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 7:00 pm

HD

A significant bearish stance has been taken on Home Depot (NYSE:HD) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is split between 38% bullish and 61% bearish. The whales have been targeting a price range from $280.0 to $350.0 for Home Depot over the last 3 months. The price of HD is currently down -1.33% at $328.65. Several financial institutions have maintained their ratings on Home Depot, with price targets ranging from $333 to $360.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 7:00 pm

IMAB

Analysts have provided bullish ratings for I-MAB (NASDAQ:IMAB) in the last quarter. In the last 3 months, 4 analysts have offered 12-month price targets for I-MAB, with an average price target of $23.0, a decrease from the previous average price target of $25.00.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 7:00 pm